Chronic News and Research

RSS

Activities of TAT fully consolidated into Geron

Geron Corporation today announced that the activities of TA Therapeutics, its joint venture with Hong Kong University of Science and Technology, are being fully consolidated into Geron.

15 Jul 2010

Active with Asthma: Free event to teach children, families how to manage the disease

On Friday, August 13th, children between the ages of 6 and 14 will participate in the American Lung Association in Iowa's asthma education event at Principal Park. This program provides children the chance to experience outdoor fun in a medically-supervised environment while learning to understand and manage their asthma.

15 Jul 2010

ConvaTec provides support to develop guidelines for NPWT

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has provided support for the development of guidelines for the appropriate use of negative pressure wound therapy in the spectrum of wound healing. Unique to these guidelines are recommendations for integrating NPWT into a comprehensive plan of care that includes moist wound healing dressings and other treatment modalities.

15 Jul 2010

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.

15 Jul 2010

Mizzou Advantage researchers examine food-related issues to find solutions for future

Many of society's most challenging health issues, including obesity, nutritional shortages and chronic disease, are related to food. University of Missouri researchers are examining the multiple facets of food and how it impacts our lives - from medicine and research to policy and law to education and business.

15 Jul 2010

IBM and Peking University People's Hospital build evidence-based patient centric care system

IBM and Peking University People's Hospital have built an evidence-based patient centric care (ePC3) system to enable cooperation and resource sharing among medical services providers for improved patient care.

15 Jul 2010

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.

15 Jul 2010

Florida Medicaid recipients make fewer trips to doctors; Calif. payments to health clinics in jeopardy; Texas addresses nursing shortage

Northeast Florida's Medicaid recipients are making fewer trips to the doctor for chronic illnesses since state officials outsourced the government-subsidized health insurance program to private managed care companies. But it remains unclear from the analysis performed by the Florida Agency for Health Care Administration, which oversees the state's Medicaid program, whether they're healthier for it. Medicaid reform was launched in 2006 in Duval and Broward counties to test whether HMOs could rein in the state's Medicaid spending.

15 Jul 2010

BARRX Medical closes $15 million Series D financing

BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.

14 Jul 2010

SANUWAVE Health introduces orthoPACE device in Europe

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports the European launch of the orthoPACE device intended for use in orthopedic, trauma and sports medicine indications following CE mark approval last month.

14 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

First Lady, HHS Secretary to discuss new preventive health care coverage under Affordable Care Act

On Wednesday, at 2:15 PM EDT, First Lady Michelle Obama, Dr. Jill Biden, HHS Secretary Kathleen Sebelius will join doctors, nurses, families, and leaders from health community to make an announcement regarding new preventive health care coverage made available under the Affordable Care Act at George Washington University Hospital.

14 Jul 2010

No valid, adequate criteria for certifying an illness as terminal: Study

Physicians that have to decide whether an illness is terminal think that "there are not valid and adequate criteria for certifying that an illness is terminal". This is the conclusion drawn from a pioneer study conducted at the University of Granada, and recently published in the International Journal of Clinical and Health Psychology (IJCHP).

14 Jul 2010

AD may lead to increased risk of comorbid conditions, research shows

Pfizer Inc., together with its collaborator on the Alzheimer's Immunotherapy Program, Janssen Alzheimer Immunotherapy, presented new research this week at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 from two podium and four poster presentations.

14 Jul 2010

Experts discuss long-term viability of cost containment measures in health care reform bill

Leading experts in health policy and the economics of health care gathered in Washington, D.C. today to discuss the long-term viability of cost containment measures in the Patient Protection and Affordable Care Act, such as prevention and disease management, in an environment with increasing downward fiscal pressures.

14 Jul 2010

Slow-starting high risk pools look for bigger wave of enrollees, other reform issues

States have seen a "slow trickle" of enrollees for new federally funded high-risk pools but are expecting more to begin enrolling as word spreads about the coverage option, Politico reports.

14 Jul 2010

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

Zogenix, Inc., a privately held pharmaceutical company, announced that it has secured a $35 million debt facility led by Oxford Finance Corporation which also included Silicon Valley Bank. The facility consists of a $25 million term loan and a $10 million revolving line of credit. Concurrently, all existing Zogenix investors, including Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Abingworth Management, and Chicago Growth Partners, have provided an additional $15 million investment.

14 Jul 2010

LSUHSC Professor awarded $2.1M grant to determine role of PCP

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to determine the role and identify which T-helper cells fight the opportunistic infection, Pneumocystis carinii pneumonia, which can be a complication of HIV/AIDS.

14 Jul 2010

ChemGenex agrees with FDA on potential regulatory path to progress OMAPRO for CML

ChemGenex Pharmaceuticals Limited announced today it has agreed with the U.S. Food and Drug Administration (FDA) on a potential regulatory path to progress OMAPRO™ (omacetaxine mepesuccinate) for the treatment of patients with Chronic Myeloid Leukemia (CML).

14 Jul 2010

Emotions play important role when certifying patients' terminal stage: Research

A research conducted at the University of Granada revealed that emotions play an important role when health professionals have to certify that a patient is in terminal stage. To the purpose of this research, a qualitative study was undertaken with a sample of 42 participants. Participants were thoroughly interviewed, with the aim of analyzing the approach and language employed by health professionals treating terminally-ill patients.

13 Jul 2010

Chronic News and Research

Activities of TAT fully consolidated into Geron

Active with Asthma: Free event to teach children, families how to manage the disease

ConvaTec provides support to develop guidelines for NPWT

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

Mizzou Advantage researchers examine food-related issues to find solutions for future

IBM and Peking University People's Hospital build evidence-based patient centric care system

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

Florida Medicaid recipients make fewer trips to doctors; Calif. payments to health clinics in jeopardy; Texas addresses nursing shortage

BARRX Medical closes $15 million Series D financing

SANUWAVE Health introduces orthoPACE device in Europe

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

First Lady, HHS Secretary to discuss new preventive health care coverage under Affordable Care Act

No valid, adequate criteria for certifying an illness as terminal: Study

AD may lead to increased risk of comorbid conditions, research shows

Experts discuss long-term viability of cost containment measures in health care reform bill

Slow-starting high risk pools look for bigger wave of enrollees, other reform issues

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

LSUHSC Professor awarded $2.1M grant to determine role of PCP

ChemGenex agrees with FDA on potential regulatory path to progress OMAPRO for CML

Emotions play important role when certifying patients' terminal stage: Research

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News